Introduction: Who Should Undergo Diagnostics

If you have been diagnosed with non-Hodgkin’s lymphoma and have completed your first round of treatment, regular monitoring becomes an essential part of your care. Diagnostics are particularly important for anyone whose cancer did not shrink as expected during initial treatment, or for those who notice symptoms returning after a period of improvement. Refractory lymphoma describes situations where the lymphoma cells continue to grow despite treatment, or when the response to treatment doesn’t last very long.^[1][4]

You should seek diagnostic testing if you experience symptoms that might suggest your lymphoma has not responded to treatment or has returned. After completing your first course of treatment, your doctor will tell you about specific symptoms to watch for. These warning signs might include swollen lymph nodes appearing in your neck, armpits, or groin, unexplained weight loss without trying, persistent fevers, drenching night sweats that soak your sheets, or ongoing fatigue that doesn’t improve with rest.^[8][13]

The timing of diagnostic testing depends on your individual situation. If you have completed treatment and achieved remission—meaning no evidence of lymphoma shows up on tests and scans—you’ll have regular follow-up appointments to check how you’re doing and whether you have any problems or concerns. You can contact your healthcare team between these scheduled appointments if you notice any worrying symptoms or changes in your body.^[8]

Diagnostic testing is also advisable if your symptoms haven’t improved as much as expected during your current treatment. For instance, if lymph nodes remain swollen or new ones appear while you’re still receiving therapy, your doctor may recommend additional tests to understand what’s happening. This helps determine whether the treatment needs to be adjusted or changed entirely.^[1]

Classic Diagnostic Methods for Identifying Refractory Lymphoma

When doctors suspect that non-Hodgkin’s lymphoma hasn’t responded to treatment or has returned, they use several established diagnostic methods to confirm their suspicions and understand the extent of the problem. These tests help distinguish refractory lymphoma from other conditions and provide crucial information about the best next steps for treatment.

Blood Tests

Blood tests are among the first diagnostic tools your doctor will use. These tests examine your blood cells and can reveal important information about how your body is responding to lymphoma. Your healthcare provider will look at your complete blood count, which measures different types of cells in your blood, including white blood cells, red blood cells, and platelets. When lymphoma is active or not responding to treatment, these counts may be abnormal.^[6]

Blood tests also check for specific markers or substances that can indicate lymphoma activity. For example, elevated levels of certain proteins might suggest that the cancer is still present or growing. Your doctor may also test how well your organs, particularly your liver and kidneys, are functioning, as lymphoma can sometimes affect these organs.^[6]

Medical Imaging Scans

Imaging scans create detailed pictures of the inside of your body, allowing doctors to see where lymphoma cells might be located and whether they’re responding to treatment. Several types of scans are commonly used to diagnose refractory non-Hodgkin’s lymphoma.

CT scans (computed tomography) use X-rays taken from different angles to create cross-sectional images of your body. These scans can show enlarged lymph nodes or masses that suggest active lymphoma. CT scans are particularly useful for examining your chest, abdomen, and pelvis, where lymph nodes are commonly affected.^[8]

PET scans (positron emission tomography) work differently from CT scans. Before the scan, you receive a small amount of radioactive sugar through an injection. Cancer cells, which are very active, absorb more of this sugar than normal cells, causing them to light up on the scan. PET scans are especially helpful in determining whether lymphoma is still active after treatment or if what appears on a CT scan is just scar tissue from previous treatment.^[8]

Lymph Node Biopsy

A biopsy involves removing a small sample of tissue so it can be examined under a microscope. When doctors suspect refractory lymphoma, they may recommend another lymph node biopsy, even if you had one when you were first diagnosed. This is because lymphoma cells can change over time, and understanding these changes helps doctors choose the most effective treatment.^[8][13]

During the biopsy procedure, a surgeon removes all or part of a lymph node. The tissue sample is sent to a laboratory where specialists examine the cells to confirm whether lymphoma is present and what type it is. Sometimes, doctors discover that the lymphoma has transformed into a more aggressive form, which would require different treatment approaches.^[1]

Physical Examination

Your doctor will also perform a thorough physical examination. They will feel for swollen lymph nodes in your neck, armpits, and groin—areas where lymph nodes are close to the surface and easy to examine. They’ll also check your abdomen to see if your liver or spleen is enlarged, as these organs are part of the lymphatic system and can be affected by lymphoma.^[8][13]

During the examination, your doctor will ask about symptoms you’ve been experiencing. They’ll want to know about B symptoms, a specific group of symptoms that includes fever, night sweats, and unexplained weight loss. The presence or absence of these symptoms helps classify your lymphoma and guide treatment decisions.^[6]

Additional Tests to Understand Disease Extent

To get a complete picture of the lymphoma, doctors may order additional tests. A bone marrow biopsy checks whether lymphoma cells have spread to the bone marrow, the soft tissue inside your bones where blood cells are made. This involves taking a small sample of bone marrow, usually from your hip bone, using a special needle.^[6]

If there’s concern that lymphoma might have spread to your brain or spinal cord, your doctor may recommend a lumbar puncture, also called a spinal tap. This procedure involves inserting a needle between the bones of your lower spine to collect a small amount of cerebrospinal fluid, which is then tested for cancer cells.^[6]

These diagnostic methods work together to create a comprehensive understanding of your condition. The information they provide helps your doctor determine whether your lymphoma is truly refractory, how extensive it is, and what treatment options might work best for you. Because refractory lymphoma can be challenging to manage, getting an accurate and complete diagnosis is essential for developing an effective treatment plan.^[8][13]

Diagnostics for Clinical Trial Qualification

Clinical trials offer access to new and experimental treatments that may benefit people with refractory non-Hodgkin’s lymphoma. However, joining a clinical trial requires meeting specific criteria, and various diagnostic tests are used to determine whether you qualify. Understanding these requirements can help you know what to expect if you’re considering participation in a trial.

General Health Assessment Tests

Before enrolling in a clinical trial, researchers need to understand your overall health status. This goes beyond just evaluating your lymphoma—they need to know if your body is strong enough to handle experimental treatments, which can sometimes be more intensive than standard therapies.^[2]

Blood tests play a major role in this assessment. Researchers will check your blood cell counts to ensure your bone marrow is producing enough healthy cells. They’ll also test your liver and kidney function because these organs process medications and eliminate them from your body. If these organs aren’t working well enough, you might not be able to safely participate in certain trials.^[2]

Your heart function may also be evaluated, especially if the trial involves treatments that could affect your heart. An electrocardiogram (ECG or EKG) records the electrical activity of your heart, while an echocardiogram uses sound waves to create images of your heart’s structure and function. These tests help ensure that experimental treatments won’t put excessive strain on your heart.^[7]

Specific Lymphoma Characteristics Testing

Many clinical trials for refractory non-Hodgkin’s lymphoma are testing treatments that target specific features of cancer cells. To qualify for these trials, your lymphoma must have certain characteristics. Diagnostic tests identify these features by examining your lymphoma cells in detail.

One important test looks for specific proteins on the surface of lymphoma cells. For example, some trials require that your lymphoma cells have a protein called CD19 or CD20. These proteins act like address labels, helping immune system cells or targeted drugs find and attack the cancer. A tissue sample from a biopsy is tested using special techniques that can identify these proteins.^[7][4]

Genetic testing of your lymphoma cells may also be required. Scientists have discovered that some lymphomas have specific genetic changes or mutations that make them grow and spread. Certain clinical trials test treatments designed to work against these specific mutations. A sample of your lymphoma tissue will be analyzed in a laboratory to look for these genetic changes.^[2]

Previous Treatment Documentation

Clinical trials for refractory lymphoma typically require detailed documentation of what treatments you’ve already received and how your lymphoma responded. This includes records of all chemotherapy regimens, targeted therapies, radiation treatments, or stem cell transplants you’ve undergone.^[2]

Many trials specifically recruit patients who have relapsed or not responded after receiving at least two previous lines of therapy. Your medical team will need to provide evidence showing that your lymphoma either didn’t shrink with previous treatments or came back after initially responding. This documentation might include previous scan results, pathology reports, and treatment records.^[7]

Performance Status Evaluation

Researchers need to know how well you can perform everyday activities. This is called your performance status, and it’s an important factor in determining trial eligibility. A doctor or nurse will assess your ability to care for yourself, walk around, work, and do normal activities.^[2]

Performance status is usually rated on a scale. A higher score means you’re more active and capable of taking care of yourself, while a lower score indicates you need more assistance with daily activities. Most clinical trials require participants to have a certain level of functioning because experimental treatments can be demanding on the body.^[2]

Disease Staging and Extent Assessment

Before enrolling in a clinical trial, you’ll likely need current imaging scans to show where your lymphoma is located and how much disease is present. This is called staging, and it helps researchers understand the extent of your cancer. CT scans, PET scans, or both are commonly used for this purpose.^[7]

Some trials only accept patients with a certain stage of disease. For instance, a trial might be designed for people with advanced-stage lymphoma that has spread to multiple parts of the body. Others might focus on patients with smaller amounts of disease. The staging information helps ensure that the trial includes patients who are most likely to benefit from the treatment being studied.^[7]

Specialized Tests for Advanced Therapies

Certain cutting-edge treatments being tested in clinical trials require very specific diagnostic tests. For example, trials testing CAR T-cell therapy—a treatment that modifies your own immune cells to fight cancer—need to collect and test your immune cells before you can enroll. This helps researchers determine whether you have enough healthy immune cells to create the treatment.^[4][7]

If a trial involves treatments that target the immune system in other ways, you may need tests to check for autoimmune conditions or previous infections that could interfere with the experimental therapy. These additional tests ensure that participating in the trial won’t cause unexpected complications.^[7]

The diagnostic process for clinical trial qualification can seem extensive, but each test serves an important purpose. These requirements protect your safety while helping researchers gather reliable information about new treatments. If you’re interested in clinical trials, talk with your healthcare team about which trials might be appropriate for your situation and what diagnostic tests you would need to complete.^[2]